sigma-tau i.f.r. S.p.A.

Quick facts

Phase 2 pipeline

• Eurartesim dispersible oral tablet · Infectious Disease
  Eurartesim is a fixed-dose combination of dihydroartemisinin and piperaquine, targeting the hemozoin formation in Plasmodium parasites to treat malaria.
• eurartesim film coated tablet

Phase 1 pipeline

• Eurartesim · Other
• Riamet®
• ST1968

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• sigma-tau i.f.r. S.p.A. portfolio CI brief
• sigma-tau i.f.r. S.p.A. pipeline updates RSS

Related

• Sector hub: All tracked pharma companies